A2M and Hepatic fibrosis: Both significant and advanced hepatic fibrosis could be predicted by a novel panel of serum biomarkers (Egy-Score) composed of CA 19-9, age, alpha-2- macroglobulin, total bilirubin, albumin and platelet count (in a regression equation) with good sensitivity and specificity.